CME Credit Information
AMA Category 1 credits that also serve as Self Assessment Module (SAM) credits, as defined by the American Board of Radiology. Other specialists should consult their respective specialty board for applicability. SA-CME credits are accepted by the ARDMS, CCI and Sonography Canada.
After completing this activity the learner will:
- Understand the demographics, pathophysiology, risk factors, and signs and symptoms of gangrenous, acalculous, and emphysematous cholecystitis.
- Be able to recognize the sonographic findings of gangrenous, acalculous, and emphysematous cholecystitis.
Physicians, sonographers, vascular technologists and others who perform and/or interpret vascular ultrasound.
The Institute for Advanced Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Institute for Advanced Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
These credits are accepted by the American Registry for Diagnostic Medical Sonography (ARDMS).
For further information on the applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.
Faculty & Disclosure
Sharlene A. Teefey MD
Professor of Radiology
Abdominal Imaging Section
Washington University School of Medicine
St. Louis, Mo.
In compliance with the Essentials and Standards of the ACCME, the author of this CME tutorial is required to disclose any significant financial or other relationships they may have with the manufacturer(s) of any commercial product(s) or provider(s) of any commercial service(s) discussed in this program.
Dr. Sharma discloses no relevant financial interests with commercial interests.
No one at IAME who had control over the planning or content of this activity has relationships with commercial interests.